Top

Published in:

22-11-2023 | Systemic Lupus Erythematosus | LETTERS OF BIOMEDICAL AND CLINICAL RESEARCH

Underutilization of ambulatory blood pressure monitoring in locally and nationally representative samples of patients with childhood-onset systemic lupus erythematosus

Authors: Joyce C. Chang, Mary Beth F. Son, Gabrielle Alonzi, Pamela F. Weiss, Ankana Daga

Published in: Clinical Rheumatology | Issue 3/2024

Excerpt

Ambulatory blood pressure monitoring (ABPM) has well-established advantages over clinic blood pressure (BP) in children and adults [1]. Uncontrolled ambulatory hypertension, especially nocturnal hypertension, is associated with greater target organ damage in patients with chronic kidney disease (CKD) and obesity, as well as increased risk of cardiovascular death in the general population [1‐3]. Why then is uptake of ABPM for patients with childhood-onset systemic lupus erythematosus (SLE), a condition with known cardiovascular risk, so abysmal? …

Flynn JT, Urbina EM, Brady TM et al (2022) ambulatory blood pressure monitoring in children and adolescents: 2022 update: a scientific statement from the American Heart Association. Hypertension 79:e114–e124. https://doi.org/10.1161/HYP.0000000000000215CrossRefPubMed

Borrelli S, Garofalo C, Gabbai FB et al (2023) Dipping status, ambulatory blood pressure control, cardiovascular disease, and kidney disease progression: a Multicenter Cohort Study of CKD. Am J Kidney Dis 81:15-24.e1. https://doi.org/10.1053/j.ajkd.2022.04.010CrossRefPubMed

Staplin N, de la Sierra A, Ruilope LM et al (2023) Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients. The Lancet 401:2041–2050. https://doi.org/10.1016/S0140-6736(23)00733-XCrossRef

Avar Aydin PO, Shan J, Brunner HI, Mitsnefes MM (2018) Blood pressure control over time in childhood-onset systemic lupus erythematous. Lupus 27:657–664. https://doi.org/10.1177/0961203317751061CrossRefPubMed

Mazo A, Duong MD, Sharma M et al (2022) Ambulatory blood pressure patterns in children, adolescents, and young adults with childhood-onset systemic lupus erythematosus and normal office blood pressure. J Clin Rheumatol 28:328–331. https://doi.org/10.1097/RHU.0000000000001884CrossRefPubMed

Canpolat N, Kasapcopur O, Caliskan S et al (2013) Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. Pediatr Nephrol 28:305–313. https://doi.org/10.1007/s00467-012-2317-3CrossRefPubMed

Chang JC, Xiao R, Meyers KE et al (2020) Nocturnal blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset lupus. Arthritis Res Ther 22:129. https://doi.org/10.1186/s13075-020-02224-w

Sabio JM, Martinez-Bordonado J, Sánchez-Berná I et al (2015) Nighttime blood pressure patterns and subclinical atherosclerosis in women with systemic lupus erythematosus. J Rheumatol 42:2310–2317. https://doi.org/10.3899/jrheum.150531CrossRefPubMed

Chang JC, Weiss PF, Xiao R et al (2022) Use of renin angiotensin aldosterone system inhibitors in children with lupus and time to glucocorticoid discontinuation. Kidney Int 102:395–404. https://doi.org/10.1016/j.kint.2022.04.023CrossRefPubMedPubMedCentral

10.

Flynn JT, Kaelber DC, Baker-Smith CM et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https://doi.org/10.1542/peds.2017-1904CrossRefPubMed

Title: Underutilization of ambulatory blood pressure monitoring in locally and nationally representative samples of patients with childhood-onset systemic lupus erythematosus
Authors: Joyce C. Chang
Mary Beth F. Son
Gabrielle Alonzi
Pamela F. Weiss
Ankana Daga
Publication date: 22-11-2023
Publisher: Springer International Publishing
Keywords: Systemic Lupus Erythematosus
Hypertension
Hypertension
Lupus Nephritis
Chronic Kidney Disease
Published in: Clinical Rheumatology / Issue 3/2024
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-023-06819-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2024

The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients

Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review

Validation of new immune and inflammation-related diagnostic biomarkers for RA

Myofibroblast and pro-fibrotic cytokines in fibrosis of IgG4-related disease (IgG4-RD) patients from South Asia: preliminary data

Global trends in research of melanoma differentiation-associated gene 5: a bibliometric analysis from 2002 to 2022

Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage